Macrogenics Inc (MGNX)
4.55
-0.08
(-1.73%)
USD |
NASDAQ |
May 24, 16:00
4.56
+0.01
(+0.22%)
After-Hours: 20:00
Macrogenics SG&A Expense (Quarterly): 14.71M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 14.71M |
December 31, 2023 | 12.56M |
September 30, 2023 | 12.41M |
June 30, 2023 | 13.69M |
March 31, 2023 | 13.53M |
December 31, 2022 | 13.67M |
September 30, 2022 | 15.36M |
June 30, 2022 | 13.67M |
March 31, 2022 | 16.25M |
December 31, 2021 | 15.58M |
September 30, 2021 | 17.16M |
June 30, 2021 | 15.23M |
March 31, 2021 | 15.04M |
December 31, 2020 | 12.56M |
September 30, 2020 | 9.732M |
June 30, 2020 | 10.22M |
March 31, 2020 | 10.23M |
December 31, 2019 | 11.89M |
September 30, 2019 | 11.83M |
June 30, 2019 | 12.12M |
March 31, 2019 | 10.22M |
December 31, 2018 | 10.55M |
September 30, 2018 | 9.584M |
June 30, 2018 | 11.13M |
Date | Value |
---|---|
March 31, 2018 | 9.235M |
December 31, 2017 | 8.404M |
September 30, 2017 | 8.403M |
June 30, 2017 | 8.384M |
March 31, 2017 | 7.462M |
December 31, 2016 | 9.235M |
September 30, 2016 | 7.224M |
June 30, 2016 | 7.239M |
March 31, 2016 | 6.133M |
December 31, 2015 | 6.715M |
September 30, 2015 | 6.021M |
June 30, 2015 | 5.346M |
March 31, 2015 | 4.683M |
December 31, 2014 | 4.845M |
September 30, 2014 | 3.678M |
June 30, 2014 | 4.145M |
March 31, 2014 | 3.258M |
December 31, 2013 | 3.764M |
September 30, 2013 | 1.986M |
June 30, 2013 | 1.503M |
March 31, 2013 | 3.833M |
December 31, 2012 | 3.547M |
September 30, 2012 | 1.514M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
9.732M
Minimum
Sep 2020
17.16M
Maximum
Sep 2021
13.37M
Average
13.60M
Median
SG&A Expense (Quarterly) Benchmarks
Moderna Inc | 274.00M |
Allurion Technologies Inc | 12.53M |
Novavax Inc | 86.80M |
United Therapeutics Corp | 144.40M |
MEI Pharma Inc | 4.609M |